StonvexLoading…
StonvexStonvexStonvexCore line items from NBIX's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $2.86B | $2.36B | $1.89B | $1.49B |
Operating Income | $619.10M | $570.50M | $250.90M | $249.00M |
Net Income | $478.60M | $341.30M | $249.70M | $154.50M |
EPS (Diluted) | $4.67 | $3.29 | $2.47 | $1.56 |
Total Assets | $4.63B | $3.72B | $3.25B | $2.37B |
Total Liabilities | $1.38B | $1.13B | $1.02B | $660.90M |
Cash & Equivalents | $713.00M | $233.00M | $251.10M | $262.90M |
Free Cash Flow OCF − CapEx | $748.70M | $557.20M | $361.60M | $322.90M |
Shares Outstanding | 100.10M | 99.40M | 98.70M | 96.50M |